key: cord-0690002-3kqpkr60 authors: Alwaheed, Abrar; Alalwan, Mohannad; Aldakhlan, Hasan; Albeladi, Feda title: Necrotizing Pancreatitis with Prortal Vein Thrombosis in Young Patient with COVID-19 date: 2022-03-19 journal: J Infect Public Health DOI: 10.1016/j.jiph.2022.03.009 sha: 0f586d603d4fb0d8e1c65a34b8d1c6b9d042c0a0 doc_id: 690002 cord_uid: 3kqpkr60 The current pandemic of the novel coronavirus disease 2019 (COVID-19) originated in Wuhan, China in December 2019. The most common clinical manifestations are fever, fatigue, and cough. Other common symptoms include anorexia, chest tightness and shortness of breath. Extrapulmonary manifestations including gastrointestinal symptoms were also reported in patients with COVID-19 infection. It has been found that the ACE2 receptor of SARS-CoV-2 is expressed more in the pancreas than in the lungs. However, only few cases reported with pancreatic injury were caused by COVID-19. In this paper we report a young patient presenting with acute necrotizing pancreatitis that is complicated with portal vein thrombosis and found to have COVID-19 infection. The current pandemic of the novel coronavirus disease 2019 (COVID-19) originated in Wuhan, China in December 2019. The most common clinical manifestations are fever, fatigue, and cough. Other common symptoms include anorexia, chest tightness and shortness of breath. Extrapulmonary manifestations including gastrointestinal symptoms were also reported in patients with COVID-19 infection. It has been found that the ACE2 receptor of SARS-CoV-2 is expressed more in the pancreas than in the lungs. However, only few cases reported with pancreatic injury were caused by COVID-19. In this paper we report a young patient presenting with acute necrotizing pancreatitis that is complicated with portal vein thrombosis and found to have COVID-19 infection. Thrombosis, COVID-19, Acute pancreatitis, Portal vein thrombosis A 15-year-old Saudi patient who is medically free, presented to emergency department in June 2021 with severe epigastric pain for three days, radiating to the back and associated with nausea, vomiting and fever. He reported no similar episodes before and had no respiratory symptoms. The patient denied any travel history, alcohol consumption, drug abuse or any medications. He did not receive any dose of COVID-19 vaccine and he reported a history of contact with positive COVID-19 cases in his family. On physical examination, he was in severe pain with the following vital signs: heart rate 120 beats per minute, respiratory rate 20 breath per min, blood pressure 130/80 mmHg, temperature 36.5°C, and oxygen saturation 97% on room air. The abdomen was soft with severe epigastric tenderness. Laboratory workup on admission showed leukocytosis with raised inflammatory markers and his serum lipase was significantly elevated, as summarized on (Table 1) . J o u r n a l P r e -p r o o f In addition, nasopharyngeal swab for SARS-CoV-2 was taken and tested positive, but his chest x-ray was unremarkable (Figure 2 ). The patient underwent percutaneous drainage of the necrotic collection by interventional radiology, cultures including aerobe, anaerobe, and fungal were sent to microbiology lab and were negative. Furthermore, thrombophilia workup including antiphospholipid antibodies was unremarkable. He was then managed with therapeutic low molecular weight heparin (Enoxaparin) for Portal Vein Thrombosis (PVT). After drainage and starting him on anticoagulant, he was significantly improving clinically and radiologically, and was discharged on Rivaroxaban for total of three months. Corona virus disease-19 (COVID-19) had been advocated pandemic in March 2020 [1] . It mainly affects the respiratory system with a variable clinical presentation, ranging from a flu-like syndrome with mild respiratory symptoms, viral pneumonia with acute respiratory failure, and multiple organ dysfunction [2] . However, extra J o u r n a l P r e -p r o o f pulmonary manifestations have been reported in illustrative studies from China, such as gastrointestinal symptoms which can be as high as 50% [3] These symptoms include nausea (17.3%), diarrhea (12.9%), anorexia (12.2%), abdominal pain (5.8%), belching (5%) and emesis (5%) [4] . Some articles have reported acute necrotizing pancreatitis in many patients due to COVID-19 infection. Wang et al. were the first to describe nine patients with acute pancreatitis in a case series of 52 patients with COVID-19 [5] . Although the exact pathogenesis of pancreatitis caused by COVID-19 is still unclear with many proposed theories, it has been reported in one study that ACE2 receptor is expressed more in the pancreas than the lungs [6] . This renders the pancreas to be a target for SARS-CoV-2 which leads to pancreatic injury from the direct cytopathic effect mediated by the local replication of SARS-CoV-2 [7] . [8] [9] [10] [11] . Portal vein thrombosis usually occurs in association with liver cirrhosis, hepatic malignancy or in patients with inherited or acquired thrombophilia, and it is rarely due to viral infection [12] . Additionally, portal vein thrombosis can present as a complication of severe pancreatitis particularly in cases with pancreatic necrosis, but it is uncommon complication ( Table 2 ) [13] [14] . Clinical characteristics of 3062 COVID-19 patients: a meta-analysis A Narrative Review of Influenza: A Seasonal and Pandemic Disease Gastrointestinal Symptoms and Outcomes in Hospitalized Coronavirus Disease Clinical Insights into the Gastrointestinal Manifestations of COVID-19 SARS-CoV-2 leading to acute pancreatitis: an unusual presentation ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection SAGE Journals. 2021. COVID-19 Presenting as Acute Necrotizing Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis Corrigendum to "The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management SARS-CoV-2 and Portal Vein Thrombosis: A Rare Gastrointestinal Manifestation of COVID-19 COVID-19 versus HIT hypercoagulability Acute portal vein thrombosis secondary to COVID-19: a case report A Case of Acute Necrotizing Pancreatitis Complicated by Portal Vein Thrombosis Splanchnic vein thrombosis in severe acute pancreatitis: a 2-year, singleinstitution experience infection which has not been reported previously in the literature. Acute necrotizing pancreatitis is a rare complication of COVID-19 and VTE is a wellknown manifestation of it, however their co-occurrence has not been reported in the previous literature. A high clinical suspicion for unusual site thrombosis such as splanchnic vein thrombosis should be raised while investigating for gastrointestinal manifestations of SARS-COV 2 infection.